This could decrease the capacity of adipose tissue to efficiently uptake postprandial glucose and free fatty acid, which, coupled with inefficient anti-inflammatory C5L2 effects, could contribute to systemic inflammation associated with obesity and insulin resistance and is consistent with the associations with high levels of circulating lipids and lower adiponectin and HDL-C. Here, ADIPOQ is linked to Insulin resistance.